Notice2024-30872

National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
December 30, 2024

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 89 Issue 249 (Monday, December 30, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 249 (Monday, December 30, 2024)]
[Notices]
[Page 106541]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-30872]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Diabetes 
and Digestive and Kidney Diseases Advisory Council.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Diabetes and Digestive and Kidney 
Diseases Advisory Council.
    Date: May 14-15, 2025.
    Open: May 14, 2025, 8:30 a.m. to 12:00 p.m.
    Agenda: Call to order; Announcements; Consideration of Summary 
Minutes for September 2024 Council, Future Council Dates; Report 
from the Director; Speakers; Concept Clearance.
    Address: National Institutes of Health, Building 31, C Wing 6th 
Floor Conf. Room F&G, 31 Center Drive, Bethesda, MD 20892, (In 
Person and Virtual Meeting).
    Open: May 14, 2025, 1:00 p.m. to 2:30 p.m.
    Agenda: KUH Open session.
    Address: National Institutes of Health, Building 31, C Wing 6th 
Floor Conf. Room B (KUH), 31 Center Drive, Bethesda, MD 20892, (In 
Person and Virtual Meeting).
    Open: May 14, 2025, 1:00 p.m. to 2:30 p.m.
    Agenda: DEM Open session.
    Address: National Institutes of Health, Building 31, C Wing 6th 
Floor Conf. Room F&G (DEM), 31 Center Drive, Bethesda, MD 20892, (In 
Person and Virtual Meeting).
    Open: May 14, 2025, 1:00 p.m. to 2:30 p.m.
    Agenda: DDN Open session.
    Address: National Institutes of Health, Building 31, C Wing 6th 
Floor Conf. Room A (DDN), 31 Center Drive, Bethesda, MD 20892, (In 
Person and Virtual Meeting).
    Closed: May 14, 2025, 2:30 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Building 31, C Wing 6th 
Floor Conf. Room A (DDN), 31 Center Drive, Bethesda, MD 20892, (In 
Person and Virtual Meeting).
    Closed: May 14, 2025, 2:30 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Building 31, C Wing 6th 
Floor Conf. Room B (KUH), 31 Center Drive, Bethesda, MD 20892, (In 
Person and Virtual Meeting).
    Closed: May 14, 2025, 2:30 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Building 31, C Wing 6th 
Floor Conf. Room F&G (DEM), 31 Center Drive, Bethesda, MD 20892, (In 
Person and Virtual Meeting).
    Closed: May 14, 2025, 3:45 p.m. to 4:00 p.m.
    Agenda: To review and evaluate reports of Subcommittees and 
Consideration of Applications.
    Address: National Institutes of Health, Building 31, C Wing 6th 
Floor Conf. Room F&G, 31 Center Drive, Bethesda, MD 20892, (In 
Person and Virtual Meeting).
    Contact Person: Karl F. Malik, Ph.D., Director, Division of 
Extramural Activities, National Institutes of Diabetes and Digestive 
and Kidney Diseases, 6707 Democracy Blvd., Room 7329, MSC 5452, 
Bethesda, MD 20892, (301) 594-4757, <a href="/cdn-cgi/l/email-protection#5b363a373230301b35323f3f3075353233753c342d"><span class="__cf_email__" data-cfemail="f29f939e9b9999b29c9b969699dc9c9b9adc959d84">[email&#160;protected]</span></a>.

    Information is also available on the Institute's/Center's home 
page: <a href="http://www.niddk.nih.gov/fund/divisions/DEA/Council/coundesc.htm">www.niddk.nih.gov/fund/divisions/DEA/Council/coundesc.htm</a>., 
where an agenda and any additional information for the meeting will 
be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: December 19, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-30872 Filed 12-27-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on December 30, 2024.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.